Photocure ASA (LON:0IMT)

Market Cap	104.35M
Revenue (ttm)	36.94M
Net Income (ttm)	-234.83K
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,941
Average Volume	3,050
Open	55.00
Previous Close	n/a
Day's Range	54.30 - 55.00
52-Week Range	40.85 - 71.90
Beta	0.78
RSI	50.84
Earnings Date	Apr 11, 2025

About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical precancerous lesions. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira; and a strategic agreemen...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1993
• Employees: 101
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0IMT

Financial Performance

Financial numbers in NOK